112 related articles for article (PubMed ID: 16080565)
1. Chemoradiation is a tolerable therapy for older adults with esophageal cancer.
Nallapareddy S; Wilding GE; Yang G; Iyer R; Javle M
Anticancer Res; 2005; 25(4):3055-60. PubMed ID: 16080565
[TBL] [Abstract][Full Text] [Related]
2. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
[TBL] [Abstract][Full Text] [Related]
8. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
9. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
10. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
12. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
[TBL] [Abstract][Full Text] [Related]
13. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
[TBL] [Abstract][Full Text] [Related]
14. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
17. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Malaisrie SC; Hofstetter WL; Correa AM; Ajani JA; Komaki RR; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Wu TT; Swisher SG
Cancer; 2006 Sep; 107(5):967-74. PubMed ID: 16874819
[TBL] [Abstract][Full Text] [Related]
18. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
19. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
Thomas CR; Berkey BA; Minsky BD; Gaspar LE; Herskovic A; Rich TA; Gunderson LL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1405-10. PubMed ID: 15050316
[TBL] [Abstract][Full Text] [Related]
20. Radiation and chemoradiation therapy for esophageal adenocarcinoma.
Bosset JF; Lorchel F; Mantion G; Buffet J; Créhange G; Bosset M; Chaigneau L; Servagi S
J Surg Oncol; 2005 Dec; 92(3):239-45. PubMed ID: 16299784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
